AAAAAA

   
Results: 1-21 |
Results: 21
A RANDOMIZED PHASE-ILL STUDY COMPARING WEEKLY FOLINIC ACID (FA) AND HIGHDOSE B-FLUOROURACIL (5-FU) WITH MONTHLY 5-FU FA D 1-5 IN UNTREATED PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA (CRC)/
Authors: WEH HJ ZSCHABER R BRAUMANN D HOELZER P HOFFMANN R BECKER K KLEEBERG UR POMPECKI R HOFFKNECHT M BENNER A HOSSFELD DK
Citation: Hj. Weh et al., A RANDOMIZED PHASE-ILL STUDY COMPARING WEEKLY FOLINIC ACID (FA) AND HIGHDOSE B-FLUOROURACIL (5-FU) WITH MONTHLY 5-FU FA D 1-5 IN UNTREATED PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA (CRC)/, Annals of oncology, 9, 1998, pp. 156-156
INTENSIFIED CONDITIONING REGIMEN FOLLOWED BY STEM-CELL TRANSPLANTATION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA
Authors: KROGER N HOFFKNECHT M SONNENBERG S KRUGER W HANEL M RENGES H DEWIT M WEH HJ KRULL A ZANDER AR
Citation: N. Kroger et al., INTENSIFIED CONDITIONING REGIMEN FOLLOWED BY STEM-CELL TRANSPLANTATION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Annals of oncology, 9, 1998, pp. 530-530
CEFTRIAXONE MONOTHERAPY IN THE TREATMENT OF 376 EPISODES WITH LOW-RISK FEBRILE NEUTROPENIA
Authors: KARTHAUS M WOLF HH EGERER G KAMPFE D HOFFKNECHT M JURGENS H
Citation: M. Karthaus et al., CEFTRIAXONE MONOTHERAPY IN THE TREATMENT OF 376 EPISODES WITH LOW-RISK FEBRILE NEUTROPENIA, Annals of oncology, 9, 1998, pp. 678-678
HIGH-DOSE CHEMOTHERAPY IN MANTLE-CELL LYMPHOMA
Authors: KRUGER N HOFFKNECHT M SCHMITZ N KRUGER W ZANDER AR
Citation: N. Kruger et al., HIGH-DOSE CHEMOTHERAPY IN MANTLE-CELL LYMPHOMA, Bone marrow transplantation, 22, 1998, pp. 2-2
BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AS HIGH-DOSE CONDITIONING THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMA AND PRIOR DOSE-LIMITING RADIATION-THERAPY
Authors: KROGER N HOFFKNECHT M HANEL M KRUGER W ZELLER W STOCKSCHLADER M DEWIT M WEH HJ KABISCH H ERTTMANN R ZANDER AR
Citation: N. Kroger et al., BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AS HIGH-DOSE CONDITIONING THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMA AND PRIOR DOSE-LIMITING RADIATION-THERAPY, Bone marrow transplantation, 21(12), 1998, pp. 1171-1175
LONG-TERM DISEASE-FREE SURVIVAL OF PATIENTS WITH ADVANCED MANTLE-CELLLYMPHOMA FOLLOWING HIGH-DOSE CHEMOTHERAPY
Authors: KROGER N HOFFKNECHT M DREGER P KRUGER W ZELLER W KRULL A STOCKSCHLADER M BITTNER S WEH HJ ZANDER AR
Citation: N. Kroger et al., LONG-TERM DISEASE-FREE SURVIVAL OF PATIENTS WITH ADVANCED MANTLE-CELLLYMPHOMA FOLLOWING HIGH-DOSE CHEMOTHERAPY, Bone marrow transplantation, 21(1), 1998, pp. 55-57
ADJUVANT CHEMOTHERAPY WITH 5-FLUOROURACIL AND FOLINIC ACID IN COLORECTAL-CANCER - EVALUATION OF TOXICITY
Authors: HARTUNG G QUEISSER W DIEZLER P HAGMULLER E EDLER L JACOB I WOJATSCHEK C SEIFERT A WEISS H WEH HJ HOFFKNECHT M CLEMENS MR FRITZE D KATZ R HARLE M
Citation: G. Hartung et al., ADJUVANT CHEMOTHERAPY WITH 5-FLUOROURACIL AND FOLINIC ACID IN COLORECTAL-CANCER - EVALUATION OF TOXICITY, Onkologie, 19(1), 1996, pp. 62-67
USE OF CRYOPRESERVED BONE-MARROW IN UNRELATED ALLOGENEIC TRANSPLANTATION
Authors: STOCKSCHLADER M KRUGER W DIECK AT HORSTMANN M ALTNODER M LOLIGER C FIEDLER W HOFFKNECHT M ERTTMANN R ZANDER A
Citation: M. Stockschlader et al., USE OF CRYOPRESERVED BONE-MARROW IN UNRELATED ALLOGENEIC TRANSPLANTATION, Bone marrow transplantation, 17(2), 1996, pp. 197-199
FATAL OUTCOME OF DISSEMINATED CANDIDOSIS AFTER ALLOGENEIC BONE-MARROWTRANSPLANTATION UNDER TREATMENT WITH LIPOSOMAL AND CONVENTIONAL AMPHOTERICIN-B - A REPORT OF 4 CASES WITH DETERMINATION OF THE MIC VALUES
Authors: KRUGER W SOBOTTKA I STOCKSCHLADER M MROSS K HOFFKNECHT M RUSSMANN B HORSTMANN M BETKER R ZANDER A
Citation: W. Kruger et al., FATAL OUTCOME OF DISSEMINATED CANDIDOSIS AFTER ALLOGENEIC BONE-MARROWTRANSPLANTATION UNDER TREATMENT WITH LIPOSOMAL AND CONVENTIONAL AMPHOTERICIN-B - A REPORT OF 4 CASES WITH DETERMINATION OF THE MIC VALUES, Scandinavian journal of infectious diseases, 28(3), 1996, pp. 313-316
EARLY RECURRENCE OR PERSISTENCE OF AUTOIMMUNE-DISEASES AFTER UNMANIPULATED AUTOLOGOUS STEM-CELL TRANSPLANTATION
Authors: EULER HH MARMONT AM BACIGALUPO A FASTENRATH S DREGER P HOFFKNECHT M ZANDER AR SCHALKE B HAHN U HAAS R SCHMITZ N
Citation: Hh. Euler et al., EARLY RECURRENCE OR PERSISTENCE OF AUTOIMMUNE-DISEASES AFTER UNMANIPULATED AUTOLOGOUS STEM-CELL TRANSPLANTATION, Blood, 88(9), 1996, pp. 3621-3625
5-FU FA IV BOLUS THERAPY VS WEEKLY HIGH-DOSE 5-FU/FA 24-HOUR INFUSIONIN METASTATIC COLORECTAL-CARCINOMA - PRELIMINARY-RESULTS OF AN ONGOING RANDOMIZED PHASE-III STUDY/
Authors: WEH HJ HOFFKNECHT M HOLZER P BRAUMANN D HOFFMAN R GELLERMANN HJ BECKER K MULLERLEILE U DRESCHER S HOSSFELD DK
Citation: Hj. Weh et al., 5-FU FA IV BOLUS THERAPY VS WEEKLY HIGH-DOSE 5-FU/FA 24-HOUR INFUSIONIN METASTATIC COLORECTAL-CARCINOMA - PRELIMINARY-RESULTS OF AN ONGOING RANDOMIZED PHASE-III STUDY/, European journal of cancer, 31A, 1995, pp. 754-754
CYCLOPHOSPHAMIDE ANTITHYMOCYTE GLOBULIN CONDITIONING OF PATIENTS WITHSEVERE APLASTIC-ANEMIA FOR MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - PRELIMINARY-RESULTS/
Authors: HORSTMANN M STOCKSCHLADER M KRUGER W HOFFKNECHT M BETKER R KABISCH H ZANDER A
Citation: M. Horstmann et al., CYCLOPHOSPHAMIDE ANTITHYMOCYTE GLOBULIN CONDITIONING OF PATIENTS WITHSEVERE APLASTIC-ANEMIA FOR MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - PRELIMINARY-RESULTS/, Annals of hematology, 71(2), 1995, pp. 77-81
CRYOPRESERVATION OF RELATED AND UNRELATED STEM-CELLS FOR ALLOGENEIC TRANSPLANTATION
Authors: STOCKSCHLADER M KRUGER W DIECK A MROSS K BERGER C ERTTMANN R CLAUSEN J HOFFKNECHT M ZANDER A
Citation: M. Stockschlader et al., CRYOPRESERVATION OF RELATED AND UNRELATED STEM-CELLS FOR ALLOGENEIC TRANSPLANTATION, Experimental hematology, 23(8), 1995, pp. 866-866
BONE-MARROW TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: STOCKSCHLADER M HEGEWISCHBECKER S KRUGER W DIECK AT MROSS K HOFFKNECHT M BERGER C KOHLSCHUTTER B MARTIN H PETERS S KABISCH H KUSE R WEH H ZANDER A
Citation: M. Stockschlader et al., BONE-MARROW TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA, Bone marrow transplantation, 16(5), 1995, pp. 663-667
USE OF CRYOPRESERVED BONE-MARROW IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: STOCKSCHLADER M KRUGER W KROSCHKE G ZELLER W HOFFKNECHT M LOLIGER C KABISCH H ZANDER A
Citation: M. Stockschlader et al., USE OF CRYOPRESERVED BONE-MARROW IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(4), 1995, pp. 569-572
EXPERIENCE WITH LIPOSOMAL AMPHOTERICIN-B IN 60 PATIENTS UNDERGOING HIGH-DOSE THERAPY AND BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: KRUGER W STOCKSCHLADER M RUSSMANN B BERGER C HOFFKNECHT M SOBOTTKA I KOHLSCHUTTER B KROSCHKE G KROGER N HORSTMANN M KABISCH H ZANDER AR
Citation: W. Kruger et al., EXPERIENCE WITH LIPOSOMAL AMPHOTERICIN-B IN 60 PATIENTS UNDERGOING HIGH-DOSE THERAPY AND BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, British Journal of Haematology, 91(3), 1995, pp. 684-690
2-CDA-TREATMENT OF UNTREATED LOW-GRADE NON-HODGKIN LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE-II-STUDY
Authors: RUMMEL M LEIMER L HOFFKNECHT M JOSTEN K KNUTH A RUCKLE H SCHUMACHER K HOSSFELD D HOELZER D BERGMANN L
Citation: M. Rummel et al., 2-CDA-TREATMENT OF UNTREATED LOW-GRADE NON-HODGKIN LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE-II-STUDY, Blood, 86(10), 1995, pp. 211-211
UNSEPARATED CD34(+)-ENRICHED, ALLOGENEIC/SYNGENEIC, RELATED/UNRELATEDPERIPHERAL STEM-CELL TRANSPLANTATIONS/INFUSIONS ALONE OR IN COMBINATION WITH ALLOGENEIC BMT IN 15 PATIENTS - A SINGLE-CENTER EXPERIENCE/
Authors: STOCKSCHLADER M ZELLER W KRUGER W CLAUSEN J DIECK AT LOLIGER C HOFFKNECHT M ZANDER A
Citation: M. Stockschlader et al., UNSEPARATED CD34(+)-ENRICHED, ALLOGENEIC/SYNGENEIC, RELATED/UNRELATEDPERIPHERAL STEM-CELL TRANSPLANTATIONS/INFUSIONS ALONE OR IN COMBINATION WITH ALLOGENEIC BMT IN 15 PATIENTS - A SINGLE-CENTER EXPERIENCE/, Blood, 86(10), 1995, pp. 419-419
USE OF CRYOPRESERVED BONE-MARROW CELLS IN UNRELATED ALLOGENEIC TRANSPLANTATION
Authors: STOCKSCHLADER M KRUGER W DIECK AT BETKER R ERTTMANN R HOFFKNECHT M ZANDER A
Citation: M. Stockschlader et al., USE OF CRYOPRESERVED BONE-MARROW CELLS IN UNRELATED ALLOGENEIC TRANSPLANTATION, Blood, 86(10), 1995, pp. 1556-1556
EFFECT OF CRYOPRESERVED DONOR BONE-MARROW ON ENGRAFTMENT AND GVHD IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: STOCKSCHLADER M KRUGER W ZELLER W KROSCHKE G HOFFKNECHT M KABISCH H ZANDER A
Citation: M. Stockschlader et al., EFFECT OF CRYOPRESERVED DONOR BONE-MARROW ON ENGRAFTMENT AND GVHD IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000722-10000722
NEUROTOXICITY FOLLOWING WEEKLY THERAPY WITH FOLINIC ACID AND HIGH-DOSE 5-FLUOROURACIL 24-H INFUSION IN PATIENTS WITH GASTROINTESTINAL MALIGNANCIES
Authors: WEH HJ BITTNER S HOFFKNECHT M HOSSFELD DK
Citation: Hj. Weh et al., NEUROTOXICITY FOLLOWING WEEKLY THERAPY WITH FOLINIC ACID AND HIGH-DOSE 5-FLUOROURACIL 24-H INFUSION IN PATIENTS WITH GASTROINTESTINAL MALIGNANCIES, European journal of cancer, 29A(8), 1993, pp. 1218-1219
Risultati: 1-21 |